Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease

Neurochemistry International

Volumn 39, Issue 5-6, 2001, Pages 409-413

  Peskind, Elaine R ^a   Griffin, W Sue T ^b   Akama, Keith T ^c   Raskind, Murray A ^a   Van Eldik, Linda J ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Cerebrospinal fluid S100B; Earlier stages; Elevated

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE SEVERITY; FACILITATION; FEMALE; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NEURITIS; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RATING SCALE;

ADULT; AGED; ALZHEIMER DISEASE; CALCIUM-BINDING PROTEINS; COGNITION; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; NERVE GROWTH FACTORS; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; S100 PROTEINS; TIME FACTORS;

EID: 0034813578     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00048-1     Document Type: Article

References (40)

1. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
2. Disulfide-linked S100β dimers and signal transduction
3. S100β protects hippocampal neurons from damage induced by glucose deprivation
4. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type
5. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
6. Overexpression of a calcium-binding protein, S100β, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice
7. Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia
8. A specific and sensitive ELISA for measuring S-100β in cerebrospinal fluid
9. Brain interleukin 1 and S100 immunoreactivity are elevated in Alzheimer disease and in Down syndrome
10. Methods for the study of cytokines in human neurodegenerative disease
11. Life-long overexpression of S100β in Down's syndrome: Implications for Alzheimer pathogenesis
12. Glial fibrillary acidic protein and A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: Relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles
13. Glial-derived proteins activate cultured astrocytes and enhance β-amyloid-induced glial activation
14. S100β induces neuronal cell death through nitric oxide release from astrocytes
15. Purification and characterization of a neurite extension factor from bovine brain
16. S-100 protein release in a range of cardiothoracic surgical procedures
17. Mechanism of glial activation by S100B: Involvement of the transcription factor NFB
18. S100β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures
19. S100β induction of the pro-inflammatory cytokine interleukin-6 in neurons
20. Increased S100β neurotrophic activity in Alzheimer disease temporal lobe
21. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
22. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease
23. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases
24. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
25. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease
26. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology
27. Amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures
28. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system
29. Astrocytosis and axonal proliferation in the hippocampus of S100β transgenic mice
30. Overexpression of S100β in Down's syndrome: Correlation with patient age and with β-amyloid deposition
31. Proteins of the brain extracellular fluid: Evidence for release of S-100 protein
32. S100β protein expression in Alzheimer's disease: Potential role in the pathogenesis of neuritic plaques
33. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis
34. Glial-neuronal interactions in Alzheimer disease: Progressive association of IL-1α+ microglia and S100β+ astrocytes with neurofibrillary tangle stage
35. Overexpression of the neuritotrophic cytokine S100β precedes the appearance of neuritic β-amyloid plaques in APPV717F mice
36. Neuro-glial neurotrophic interaction in the S-100β retarded mouse (Polydactyly nagoya). I. Immunocytochemical and neurochemical studies
37. Normal serum concentrations of S-100 protein and changes in cerebrospinal fluid concentrations of S-100 protein during and after thoracoabdominal aortic aneurysm surgery: Is S-100 protein a biochemical marker of clinical value in detecting spinal cord ischemia?
38. S100β expression in Alzheimer's disease: Relation to neuropathology in brain regions
39. Transgenic mice overexpressing the neurotrophic factor S100β show neuronal cytoskeletal and behavioral signs of altered aging processes: Implications for Alzheimer's disease and Down's syndrome
40. Learning and memory in S100-β transgenic mice: An analysis of impaired and preserved function